https://clinicaltrials.gov/ct2/show/NCT04087590?type=Intr&cond=COPD&sfpd_d=14&sel_rss=new14 Impact of Inhaled PT003 on Complexity and Variability of Tidal Breathing and Oscillatory Mechanics in Stable COPD Patient Condition : Copd Intervention : Drug: Formoterol-glycopyrronium co suspension (PT003) Sponsors : University Hospital, Lille; AstraZeneca Not yet recruiting NCT04087590 Thu, 12 Sep 2019 12:00:00 EDT